As the role of SIRT1-mediated autophagy in metabolic disorders have been increasingly highlighted, clinical and animal studies have been conducted to validate the use potential SIRT1 modulator as a therapeutic intervention for endocrine disorders by targeting SIRT1-autophagy axis. The gene discussed is SIRT1; the disease is metabolic disease.